
Laura McLaughlin MD (She/Her)
Pediatric Hematology/Oncology
Assistant Professor of Pediatrics, Pediatric Bone Marrow Transplantation & Cellular Therapeutics
Join to View Full Profile
13123 E 16th AveAurora, CO 80045
Phone+1 720-777-6740
Fax+1 720-777-7227
Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I specialize in hematopoietic cell transplant for pediatric and young adult patients with non-malignant conditions including immune dysregulation disorders, bone marrow failure syndromes, immunodeficiencies and autoimmunity. My clinical research interests include development of novel pre-transplant conditioning regimens which reduce transplant-related toxicity and decrease the incidence of graft failure and management of post-transplant complications including GVHD.
Education & Training
- University of Colorado School of Medicine Anschutz Medical CampusFellowship, Pediatric Bone Marrow Transplantation & Cellular Therapeutics, 2021 - 2022
- University of ColoradoFellowship, Pediatric Hematology/Oncology, 2018 - 2021
- Baylor College of Medicine (Houston)Residency, Pediatrics, 2015 - 2018
- Florida State University College of MedicineClass of 2015
- University of FloridaBS, Microbiology & Cell Science, Magna Cum Laude, 2007 - 2009
Certifications & Licensure
- KS State Medical License 2025 - Present
- CO State Medical License 2018 - 2027
- SD State Medical License 2024 - 2027
- MT State Medical License 2024 - 2026
- NE State Medical License 2024 - 2026
- NM State Medical License 2023 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Ruxolitinib dosing for acute graft-versus-host disease in a pediatric patient receiving continuous renal replacement therapy.Teaghan T Chen, Alexandria P David, Sharon E Gordon, Laura McLaughlin
Pediatric Blood & Cancer. 2024-01-01 - 1 citationsCan allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?Laura McLaughlin, Edwin DeZoeten, Michael R Verneris
British Journal of Haematology. 2023-03-01 - 2 citationsSAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium.Seon-Hui Shim, Dejene Tufa, Renee Woods, Trahan D George, Tyler Shank
Stem Cells Translational Medicine. 2022-05-27
Books/Book Chapters
Professional Memberships
- American Society for Transplantation and Cellular TherapyMember
- Castleman Disease Collaborative NetworkMember
- Pediatric Transplantation and Cellular Therapy ConsortiumMember
- Center for International Blood and Marrow Transplant ResearchMember
External Links
- PubMed Bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/16cOoIlentsg5p/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: